NNPA NEWSWIRE — The record-breaking figure represents nearly doubling enrollment since President Joe Biden took office.
NNPA NEWSWIRE — Harris’s detailed plan appears to offer Black men a vision of leadership, opportunity, and economic empowerment, which she argues is essential for the...
NNPA NEWSWIRE — “With inflation and the rising costs of living squeezing all Pennsylvania households, Black voters 50+ are clearly looking for leaders with a plan,”...
NNPA NEWSWIRE — Over the past 12 months, average hourly earnings have increased by 4.1 percent. All employees' average workweek increased by 0.1 hours to 34.3...
NNPA NEWSWIRE — Over 30 million people in the United States have been diagnosed with both Type 1 and Type 2 diabetes—including nearly 13% of all...
NASHVILLE PRIDE — Republicans and Democrats in the United States Senate have announced a proposal of nearly three-dozen specific provisions that will reduce the cost of what...
LOS ANGELES SENTINEL — Congressman Elijah E. Cummings (D-MD), Chairman of the House Committee on Oversight and Reform, released a Committee Staff Report on the prices of...
LOS ANGELES SENTINEL — U.S. Senator Kamala D. Harris (D-CA) on Wednesday joined Senator Bernie Sanders (I-VT) and 13 Democratic colleagues to introduce the Medicare for All...
NNPA NEWSWIRE — “‘Be the Difference. Vote.’ is a non-partisan campaign whose goal is mobilizing African Americans voters — and all voters 50 and older —...
MATTHEW PERRONE, AP Health Writer WASHINGTON (AP) — Hillary Rodham Clinton’s plan to rein in prescription drug prices by reshaping how drugmakers do business is being...
Ricardo Alonso-Zaldivar, ASSOCIATED PRESS WASHINGTON (AP) — Consumer-friendly ratings of the benefits of new drugs. Limits on what patients pay. Requiring drug companies to...
(Fox News) – An independent nonprofit organization that evaluates clinical and cost effectiveness of new medicines said announced prices for a just-approved class of potent cholesterol...
(CBS News) – If you’ve gone to the pharmacy recently, there’s a good chance you may have noticed the cost of a generic drug isn’t what...
RICARDO ALONSO-ZALDIVAR, Associated Press WASHINGTON (AP) — Move over, “Obamacare.” A new poll finds Americans worried about medication costs and broadly supporting government action to curb...
MARLEY JAY, AP Business Writer NEW YORK (AP) — The Food and Drug Administration said Thursday that some doctors and pharmacies are getting confused by the...
MATTHEW PERRONE, AP Health Writer WASHINGTON (AP) — Amgen on Tuesday received European approval for its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance...
(NPR) – Some antidepressants may increase the risk of birth defects if taken early in pregnancy, while others don’t seem to pose the same risks, a...
(Bloomberg Review) – Is Thursday’s $1.2 billion antitrust settlement between the Federal Trade Commission and Teva Pharmaceutical Industries a victory for consumers? Or is it a sign...
TOM MURPHY, AP Business Writer CVS Health will pay more than $10 billion for pharmaceutical distributor Omnicare in a deal primed to feed its fast-growing specialty...
(Nature World Report) – A surprising number of workers in a wide variety of professions are misusing stimulants like Adderall, Concerta, and Vyvanse to keep...
TOM MURPHY, AP Business Writer The nation’s largest health insurer, UnitedHealth, will muscle up for its fight against rising prescription drug costs by spending more than...
(Bloomberg) — The battle over soaring U.S. drug prices is heading for the states. With the price of some treatments topping $100,000, patient groups are...
MICHAEL RUBINKAM, Associated Press MARYCLAIRE DALE, Associated Press PHILADELPHIA (AP) — A subsidiary of Johnson & Johnson pleaded guilty Tuesday to a federal criminal charge that...
The Associated Press Prescription drugs spending jumped 13 percent last year, the biggest annual increase since 2003, according to the nation’s largest pharmacy benefits manager. Express...
(Reuters) – U.S. regulators on Friday gave a green light to sales of the country’s first “biosimilar,” or copied version of a biotechnology drug, by approving Novartis’ white...